Abstract
Background
The fatality rate is a crucial metric for guiding public health policies during an ongoing epidemic. For COVID-19, the age structure of the confirmed cases changes over time, bringing a substantial impact on the real-time estimation of fatality. A ‘spurious decrease’ in fatality rate can be caused by a shift in confirmed cases towards younger ages even if the fatalities remain unchanged across different ages.
Methods
To address this issue, we propose a standardized real-time fatality rate estimator. A simulation study is conducted to evaluate the performance of the estimator. The proposed method is applied for real-time fatality rate estimation of COVID-19 in Germany from March 2020 to May 2022.
Findings
The simulation results suggest that the proposed estimator can provide an accurate trend of disease fatality in all cases, while the existing estimator may convey a misleading signal of the actual situation when the changes in temporal age distribution take place. The application to Germany data shows that there was an increment in the fatality rate at the implementation of the ‘live with COVID’ strategy.
Conclusions
As many countries have chosen to coexist with the coronavirus, frequent examination of the fatality rate is of paramount importance.
Publisher
Public Library of Science (PLoS)
Reference45 articles.
1. The Guardian. US experts question whether counting COVID cases is still the right approach; 2022. https://www.theguardian.com/us-news/2022/jan/01/us-covid-case-counts-omicron.
2. U.S. News. COVID case counts may be losing importance amid Omicron; 2022. https://www.usnews.com/news/health-news/articles/2022-01-04/covid-case-counts-may-be-losing-importance-amid-omicron.
3. Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City, China, January–February, 2020;K Mizumoto;BMC Medicine,2020
4. Estimating risk for death from coronavirus disease, China, January–February 2020;K Mizumoto;Emerging Infectious Diseases,2020
5. Assessing the severity of the novel influenza A/H1N1 pandemic;T Garske;BMJ,2009